Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals to Pay $225M to Texas to Settle Opioid Epidemic Claims - Top Class Actions
New York could get $524M under opioid settlements with Teva - ABC News
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Teva made smart decision to move to us: Allergan CEO
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva to acquire Allergan for $40B
Teva News - Latest teva News, Information & Updates - Health News -ET HealthWorld
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva CEO Schultz likely won't renew employment contract: reports
Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement | Barron's
